Problems hindering the implementation of modern technologies into pharmaceutical substance manufacturing are analyzed and classified according to the degree of negative impact. Proposals for their solution were developed considering the opportunities and constraints of implementing and scaling technologies presently in the pilot stage of development. A forecast of the emergence of new technologies at both the pilot and commercial development stages was presented.
Similar content being viewed by others
References
M. S. Guseva, Vestn. Samar. Gos. Ekonom. Univ., 10(96), 60 – 64 (2012).
I. A. Narkevich, I. N. Tarasov, Z. M. Golant, et al., Khim.-farm. Zh., 49(11), 36 – 40 (2015); Pharm. Chem. J., 49(11), 760 – 764 (2015).
I. A. Narkevich, A. A. Semin, N. S. Kartashova, et al., Khim.-farm. Zh., 50(10), 54 – 60 (2016); Pharm. Chem. J., 50(10), 698 – 703 (2016).
Acknowledgments
The present work used results obtained from project RFMEFI60115X0006 on the topic “Analysis of the state of domestic pharmaceutical research and development and predictive research and proposal preparation for the development of scientific research and education to ensure the development and implementation of API manufacturing technologies required for local drug manufacturing in the Russian Federation” with financial support of the MES of the RF according to subsidy contract No. 14.601.21.0006 dated May 14, 2015.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 51, No. 4, pp. 59 – 64, April, 2017.
Rights and permissions
About this article
Cite this article
Narkevich, I.A., Golant, Z.M., Semin, A.A. et al. Analysis of Problems Hindering Implementation of Modern Drug Technologies: Searching for Possible Solutions. Pharm Chem J 51, 312–317 (2017). https://doi.org/10.1007/s11094-017-1605-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-017-1605-4